Future costs and the future of cost-effectiveness analysis.
作者信息
Garber Alan M, Phelps Charles E
机构信息
Center for Primary Care and Outcomes Research, Center for Health Policy, VA Palo Alto Health Care System and Stanford University, Stanford, CA 94305, United States.
出版信息
J Health Econ. 2008 Jul;27(4):819-21. doi: 10.1016/j.jhealeco.2008.05.002. Epub 2008 May 3.
Abstract
摘要
相似文献
1
Future costs and the future of cost-effectiveness analysis.未来成本与成本效益分析的未来。
J Health Econ. 2008 Jul;27(4):819-21. doi: 10.1016/j.jhealeco.2008.05.002. Epub 2008 May 3.
2
Response to "Future costs and the future of cost-effectiveness analysis".对《未来成本与成本效益分析的未来》的回应
J Health Econ. 2008 Jul;27(4):822-825. doi: 10.1016/j.jhealeco.2008.05.001. Epub 2008 May 3.
3
Need for differential discounting of costs and health effects in cost effectiveness analyses.成本效益分析中成本与健康效果差异贴现的必要性。
BMJ. 2005 Aug 20;331(7514):446-8. doi: 10.1136/bmj.331.7514.446.
4
Letter: The cumulative cost of death.信件：死亡的累积代价。
Lancet. 1975 Jun 14;1(7920):1341-2. doi: 10.1016/s0140-6736(75)92347-8.
5
Should NICE's threshold range for cost per QALY be raised? No.国家卫生与临床优化研究所（NICE）每质量调整生命年（QALY）的成本阈值范围应该提高吗？不应该。
BMJ. 2009 Jan 26;338:b185. doi: 10.1136/bmj.b185.
6
Should NICE's threshold range for cost per QALY be raised? Yes.国家卫生与临床优化研究所（NICE）每质量调整生命年（QALY）的成本阈值范围应该提高吗？应该。
BMJ. 2009 Jan 26;338:b181. doi: 10.1136/bmj.b181.
7
Cost effectiveness analysis in health care: contraindications.医疗保健中的成本效益分析：禁忌症
BMJ. 2002 Oct 19;325(7369):891-4. doi: 10.1136/bmj.325.7369.891.
8
Leg ulcer care: an audit of cost-effectiveness.腿部溃疡护理：成本效益审计
Health Trends. 1995;27(4):133-6.
9
Editorial: Where the axe is falling.社论：危机降临之处。
Lancet. 1974 Sep 14;2(7881):644. doi: 10.1016/s0140-6736(74)91959-x.
10
Local health care expenditure plans and their opportunity costs.地方医疗保健支出计划及其机会成本。
Health Policy. 2015 Sep;119(9):1237-44. doi: 10.1016/j.healthpol.2015.07.007. Epub 2015 Jul 28.
引用本文的文献
1
An overview of the perspectives used in health economic evaluations.卫生经济评估中所使用观点概述。
Cost Eff Resour Alloc. 2024 May 14;22(1):41. doi: 10.1186/s12962-024-00552-1.
2
Context-Specific Estimation of Future Unrelated Medical Costs and Their Impact on Cost-Effectiveness Analyses.基于情境的未来非相关医疗费用预估及其对成本效益分析的影响。
Pharmacoeconomics. 2023 Oct;41(10):1275-1286. doi: 10.1007/s40273-023-01290-7. Epub 2023 Jun 17.
3
Incorporating future unrelated medical costs in cost-effectiveness analysis in China.将未来无关医疗费用纳入中国成本效益分析。
BMJ Glob Health. 2021 Oct;6(10). doi: 10.1136/bmjgh-2021-006655.
4
Modelling the cost-effectiveness of total knee arthroplasty: A systematic review.全膝关节置换术成本效益的建模：一项系统评价
J Orthop. 2020 Oct 8;22:485-492. doi: 10.1016/j.jor.2020.10.003. eCollection 2020 Nov-Dec.
5
Cost-utility studies in upper limb orthopaedic surgery: a systematic review of published literature.上肢矫形外科中的成本-效用研究：已发表文献的系统评价。
Bone Joint J. 2018 Nov;100-B(11):1416-1423. doi: 10.1302/0301-620X.100B11.BJJ-2018-0246.R1.
6
Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease.哪些成本至关重要？经济评估中包含的成本及其对稳定型冠状动脉疾病决策不确定性的影响。
Pharmacoecon Open. 2018 Dec;2(4):403-413. doi: 10.1007/s41669-018-0068-1.
7
Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.评估影响生育和生育的干预措施的成本效益：健康影响的衡量方式至关重要。
Med Decis Making. 2015 Oct;35(7):818-46. doi: 10.1177/0272989X15583845. Epub 2015 Apr 29.
8
Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.韩国药物经济学评价指南（第二版和更新版）：共识与妥协。
Pharmacoeconomics. 2013 Apr;31(4):257-67. doi: 10.1007/s40273-012-0021-6.
9
Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial.心脏再同步治疗的成本效益：MADIT-CRT 试验。
J Cardiovasc Electrophysiol. 2013 Jan;24(1):66-74. doi: 10.1111/j.1540-8167.2012.02413.x. Epub 2012 Aug 22.
10
Cost-effectiveness of pharmacotherapy to reduce obesity.药物治疗肥胖的成本效益。
PLoS One. 2011;6(10):e26051. doi: 10.1371/journal.pone.0026051. Epub 2011 Oct 27.
本文引用的文献
1
Satisfaction guaranteed--"payment by results" for biologic agents.满意度保证——生物制剂的“按效果付费”。
N Engl J Med. 2007 Oct 18;357(16):1575-7. doi: 10.1056/NEJMp078204.
2
Accounting for future costs in medical cost-effectiveness analysis.医疗成本效益分析中对未来成本的考量。
J Health Econ. 1997 Feb;16(1):33-64. doi: 10.1016/s0167-6296(96)00507-3.
3
Economic foundations of cost-effectiveness analysis.成本效益分析的经济基础。
J Health Econ. 1997 Feb;16(1):1-31. doi: 10.1016/s0167-6296(96)00506-1.
Zotero 插件